Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163274 | PMC |
| http://dx.doi.org/10.3389/fgene.2024.1426680 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine.
Int J Mol Sci
January 2025
Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso', National Research Council CNR, 80131 Naples, Italy.
Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality worldwide [...
View Article and Find Full Text PDFAdjuvant Immunotherapy Should Be Used in Patients With Non-Small Cell Carcinoma With a Pathologic Complete Response to Neoadjuvant Immunotherapy.
J Thorac Oncol
January 2025
Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland.
Current genetic test for ovarian cancer.
Taiwan J Obstet Gynecol
January 2025
Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Female Cancer Foundation, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. Electronic address:
Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment.
Drug Resist Updat
January 2025
Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China; The Biobank, Scientific Research Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong 518107, China. Electronic address:
Article Synopsis
- Organoids were created from a patient's primary tumor and metastatic lymph nodes, accurately mirroring the tumor's characteristics.
- Drug testing on these organoids showed distinct differences in how they responded to treatments based on their origin (primary vs. metastatic).
- This personalized approach to using organoids aids in making informed treatment decisions for gastric cancer, potentially improving patient outcomes.
The ReAct project: Bayesian networks for assessing the value of the results given activity level propositions.
Forensic Sci Int Genet
January 2025
Institute of Forensic Sciences, Forensic Genetics Unit, University of Santiago de Compostela, Spain; Genomic Medicine Group -CIMUS, University of Santiago de Compostela, Galician Foundation of Genomic Medicine, IDIS, SERGAS, Santiago de Compostela, Galicia, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!